BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7966510)

  • 21. Psychiatric comorbidity in binge-eating disorder as a function of smoking history.
    White MA; Grilo CM
    J Clin Psychiatry; 2006 Apr; 67(4):594-9. PubMed ID: 16669724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comorbid substance abuse and recovery from acute psychiatric relapse.
    Sanguineti VR; Samuel SE
    Hosp Community Psychiatry; 1993 Nov; 44(11):1073-6. PubMed ID: 8288176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing predictive factors for extended hospitalization at acute psychiatric admission.
    Hopko DR; Lachar D; Bailley SE; Varner RV
    Psychiatr Serv; 2001 Oct; 52(10):1367-73. PubMed ID: 11585954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can Trans-Syndromal Prototypes ("Types") Improve Depiction of Complex Psychiatric Cases?: An Alternative Way to Consider Concordant Comorbid Psychiatric Disorders and Their Contexts as Coherent Units for Research, Assessment, and Treatment Planning.
    Yager J
    J Nerv Ment Dis; 2021 Jan; 209(1):1-8. PubMed ID: 33141784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between comorbid psychiatric diagnoses and hospitalization-related factors among individuals with schizophrenia.
    Kessler T; Lev-Ran S
    Compr Psychiatry; 2019 Feb; 89():7-15. PubMed ID: 30557808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of mental and substance use disorders. A comparison of single and dual diagnosis patients.
    Lehman AF; Myers CP; Thompson JW; Corty E
    J Nerv Ment Dis; 1993 Jun; 181(6):365-70. PubMed ID: 8388914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing the comparability of psychiatric diagnoses in ICD-10 and DSM-III-R.
    Hiller W; Dichtl G; Hecht H; Hundt W; von Zerssen D
    Psychopathology; 1994; 27(1-2):19-28. PubMed ID: 7972636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program.
    Chen KW; Banducci AN; Guller L; Macatee RJ; Lavelle A; Daughters SB; Lejuez CW
    Drug Alcohol Depend; 2011 Nov; 118(2-3):92-9. PubMed ID: 21514751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.
    McElroy SL; Altshuler LL; Suppes T; Keck PE; Frye MA; Denicoff KD; Nolen WA; Kupka RW; Leverich GS; Rochussen JR; Rush AJ; Post RM
    Am J Psychiatry; 2001 Mar; 158(3):420-6. PubMed ID: 11229983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance abuse in an inpatient psychiatric sample.
    Brady K; Casto S; Lydiard RB; Malcolm R; Arana G
    Am J Drug Alcohol Abuse; 1991; 17(4):389-97. PubMed ID: 1746501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
    Testa A; Giannuzzi R; Sollazzo F; Petrongolo L; Bernardini L; Dain S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():65-85. PubMed ID: 23436669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personality disorders in substance abusers: relation to substance use.
    Rounsaville BJ; Kranzler HR; Ball S; Tennen H; Poling J; Triffleman E
    J Nerv Ment Dis; 1998 Feb; 186(2):87-95. PubMed ID: 9484308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal, expert, all data procedure for psychiatric diagnosis in patients with psychoactive substance use disorders.
    Kranzler HR; Kadden RM; Babor TF; Rounsaville BJ
    J Nerv Ment Dis; 1994 May; 182(5):277-83. PubMed ID: 10678309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV.
    Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R
    Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbidity of axis I psychiatric disorders in bulimia nervosa.
    Brewerton TD; Lydiard RB; Herzog DB; Brotman AW; O'Neil PM; Ballenger JC
    J Clin Psychiatry; 1995 Feb; 56(2):77-80. PubMed ID: 7852257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DSM-IV in progress. Changes in substance-related, schizophrenic, and other primarily adult disorders.
    First MB; Frances AJ; Pincus HA; Vettorello N; Davis WW
    Hosp Community Psychiatry; 1994 Jan; 45(1):18-20. PubMed ID: 8125454
    [No Abstract]   [Full Text] [Related]  

  • 37. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
    Compton MT; Weiss PS; West JC; Kaslow NJ
    Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sixteen-year predictors of substance use disorder diagnoses for patients with mental health disorders.
    Irmiter C; Barry KL; Cohen K; Blow FC
    Subst Abus; 2009; 30(1):40-6. PubMed ID: 19197780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of facility and research diagnoses in first-admission psychotic patients.
    Fennig S; Craig TJ; Tanenberg-Karant M; Bromet EJ
    Am J Psychiatry; 1994 Oct; 151(10):1423-9. PubMed ID: 8092336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of schizophrenic patients with or without coexisting substance use disorder.
    Farris C; Brems C; Johnson ME; Wells R; Burns R; Kletti N
    Psychiatr Q; 2003; 74(3):205-22. PubMed ID: 12918597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.